The current study’s T2DM patients had serum TGF-β1 levels that were higher than those of healthy people who did not have diabetes or cardiac impairment, showing that TGF-β1 is more active in T2DM patients. This evidence concerns the gene TGFB1 and type 2 diabetes mellitus.